ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
2,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
8,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
